Pharmacy Question for the Week of March 1, 2021
Question:
What is the correct way to report two drugs that are administered at the same time through two separate IV lines?
Question:
What is the correct way to report two drugs that are administered at the same time through two separate IV lines?
Question:
Can you charge an XS modifier with IVP drug administration codes?
Question:
We have a patient who received three hours of IV hydration. During that time, the patient received two different drugs by intravenous push. Can the entire three hours of IV hydration be coded with the intravenous push injections?
Question:
What is the difference between white bagging and brown bagging regarding patient supplied drugs?
Question:
I know that drugs normally billed as chemotherapy administration will be associated primarily with a code found in the J9XXX series, are there any exceptions?
Question:
Do you have any tips on revenue code 636?
Question:
Are injectable drugs such as intravenously administered drugs normally eligible for inclusion under the “incident to” benefit?
Question:
Do erythropoiesis-stimulating agents (ESAs) qualify as highly complex drugs?
Question:
Can we report 96413, 96415, or 96417 for protectant drugs or rescue therapies?
Question:
Can we bill for a sequential infusion in addition to 96413 when a single bag contains multiple drugs or substances?